Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.77 USD | -2.08% | +10.83% | -25.88% |
May. 15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
Apr. 25 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | 12.2M | Sales 2025 * | 42.86M | Capitalization | 54.83M |
---|---|---|---|---|---|
Net income 2024 * | -85M | Net income 2025 * | -39M | EV / Sales 2024 * | 4.49 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.28 x |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
23.2
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | -2.08% | ||
1 week | +4.53% | ||
Current month | -1.75% | ||
1 month | -6.81% | ||
3 months | -19.24% | ||
6 months | -16.30% | ||
Current year | -25.88% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 11.77 | -2.08% | 32,988 |
24-05-24 | 12.02 | +0.84% | 29,408 |
24-05-23 | 11.92 | -3.40% | 73,167 |
24-05-22 | 12.34 | +16.20% | 197,606 |
24-05-21 | 10.62 | -5.68% | 41,467 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.88% | 54.83M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- CDTX Stock